Sirolimus News and Research

RSS
OrbusNeich's Genous Stent safe, effective for patients at high risk of restenosis

OrbusNeich's Genous Stent safe, effective for patients at high risk of restenosis

Combination drug regimen safe and effective for renal transplant patients

Combination drug regimen safe and effective for renal transplant patients

BIOTRONIK begins comparative study of ORSIRO stent with Abbott's XIENCE PRIME stent

BIOTRONIK begins comparative study of ORSIRO stent with Abbott's XIENCE PRIME stent

Novartis Afinitor Phase III trial on tuberous sclerosis meets primary endpoint

Novartis Afinitor Phase III trial on tuberous sclerosis meets primary endpoint

Elixir DESyne Drug Eluting Coronary Stent System granted CE Mark approval

Elixir DESyne Drug Eluting Coronary Stent System granted CE Mark approval

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

Sirolimus may help treat lymphangioleiomyomatosis in women

Sirolimus may help treat lymphangioleiomyomatosis in women

OrbusNeich launches CE marked Azule Cobalt Chromium Stent

OrbusNeich launches CE marked Azule Cobalt Chromium Stent

Variation in exposure to sunlight may affect sensitivity of individuals to drugs

Variation in exposure to sunlight may affect sensitivity of individuals to drugs

OrbusNeich's Sapphire II coronary dilatation catheter is now available in the market

OrbusNeich's Sapphire II coronary dilatation catheter is now available in the market

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

U.S. FDA clears QMS Everolimus Immunoassay to prevent rejection in kidney transplants

U.S. FDA clears QMS Everolimus Immunoassay to prevent rejection in kidney transplants

Intellikine, PKD Foundation to investigate novel therapies for patients with PKD

Intellikine, PKD Foundation to investigate novel therapies for patients with PKD

Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors

Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors

Study: Drug-eluting stents outperform BMS for revascularization of CTOs

Study: Drug-eluting stents outperform BMS for revascularization of CTOs

DAPT shows positive outcomes following treatment with OrbusNeich's Genous Stent

DAPT shows positive outcomes following treatment with OrbusNeich's Genous Stent

OrbusNeich expands patent protection for Genous endothelial progenitor cell capture technology

OrbusNeich expands patent protection for Genous endothelial progenitor cell capture technology

Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES